---
title: "Aura Biosciences grants new executives stock options priced at $7.43, plus RSUs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297695014.md"
description: "Aura Biosciences granted inducement equity awards to three new executives on Sept. 1, 2026. The package includes stock options for 677,000 shares at $7.43 and RSUs for 343,009 shares. Options vest 25% after one year, then monthly over 36 months. RSUs begin vesting Sept. 15, 2027, with annual 25% tranches over three years."
datetime: "2026-09-01T20:28:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297695014.md)
  - [en](https://longbridge.com/en/news/297695014.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297695014.md)
generator: "portal-rs"
---

# Aura Biosciences grants new executives stock options priced at $7.43, plus RSUs

-   Aura Biosciences issued inducement equity awards on Sept. 1, 2026 to three newly hired executives. \* Options cover 677,000 shares at an exercise price of USD 7.43, matched to the Nasdaq close on the grant date. \* RSUs cover 343,009 shares. \* Option vesting: 25% on the first anniversary of each executive’s start date; remainder monthly over 36 months. \* RSU vesting starts Sept. 15, 2027, then annually over three years in 25% tranches. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aura Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609011628PRIMZONEFULLFEED9819741) on September 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [AURA.US](https://longbridge.com/en/quote/AURA.US.md)

## Related News & Research

- [Aura Biosciences Q2 FY26 net loss widens to $45.64 million; R&D expense rises to $30.75 million](https://longbridge.com/en/news/295525945.md)
- [Personalis-Tempus AI deal clears US antitrust waiting period under HSR Act](https://longbridge.com/en/news/301072040.md)
- [Nebius COO Nave Ophir disposes of USD 113.38 million in Class A shares](https://longbridge.com/en/news/301073075.md)
- [Alphabet Inc. $GOOG Shares Acquired by Kwmg LLC](https://longbridge.com/en/news/301171695.md)
- [LIVE MARKETS-TSMC earnings could cause another round of consensus upgrades](https://longbridge.com/en/news/301145455.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**